BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6100800)

  • 1. Morphology of the gangliosidoses.
    Goebel HH
    Neuropediatrics; 1984 Sep; 15 Suppl():97-106. PubMed ID: 6100800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biochemical basis of gangliosidoses.
    Sandhoff K; Conzelmann E
    Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
    [No Abstract]   [Full Text] [Related]  

  • 3. Synopsis: gangliosidoses.
    Schwab ME; Vassella F
    Neuropediatrics; 1984 Sep; 15 Suppl():107-9. PubMed ID: 6100793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
    Pampiglione G; Harden A
    Neuropediatrics; 1984 Sep; 15 Suppl():74-84. PubMed ID: 6100798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course of GM2 gangliosidoses. A correlative attempt.
    Schulte FJ
    Neuropediatrics; 1984 Sep; 15 Suppl():66-70. PubMed ID: 6100797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gangliosidoses and the fetal retina.
    Cogan DG; Kuwabara T; Kolodny E; Driscoll S
    Ophthalmology; 1984 May; 91(5):508-12. PubMed ID: 6330639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
    Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
    Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gangliosidoses: comparative features and research applications.
    Baker HJ; Reynolds GD; Walkley SU; Cox NR; Baker GH
    Vet Pathol; 1979 Nov; 16(6):635-49. PubMed ID: 116415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
    Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
    Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
    Sango K; Yamanaka S; Hoffmann A; Okuda Y; Grinberg A; Westphal H; McDonald MP; Crawley JN; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1995 Oct; 11(2):170-6. PubMed ID: 7550345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of lysosomal storage diseases. Pathomorphologic and biochemical possibilities].
    August CH; Holzhausen HJ; Schmidt H; Stiller D; Seidlitz G; Zschiesche M
    Zentralbl Allg Pathol; 1990; 136(5):443-53. PubMed ID: 2122616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biosynthesis and biodegradation of GM2 ganglioside].
    Hirabayashi Y; Kasakura H; Matsumoto M
    Tanpakushitsu Kakusan Koso; 1984 Sep; 29(9):708-22. PubMed ID: 6240072
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ultrastructure of inclusion bodies in gangliosidoses and ceroidolipofuscinosis. Summary of doctoral dissertation].
    Majdecki T
    Neuropatol Pol; 1979; 17(2):323-31. PubMed ID: 220565
    [No Abstract]   [Full Text] [Related]  

  • 14. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
    Harzer K
    Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic GM1 gangliosidosis presenting as dystonia: I. Clinical and pathological features.
    Goldman JE; Katz D; Rapin I; Purpura DP; Suzuki K
    Ann Neurol; 1981 May; 9(5):465-75. PubMed ID: 6791574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J; Binns HJ
    Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gangliosidoses.
    Volk BW; Adachi M; Schneck L
    Hum Pathol; 1975 Sep; 6(5):555-69. PubMed ID: 170187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical aspects of adult hexosaminidase deficiencies.
    Federico A; Palmeri S; Malandrini A; Fabrizi G; Mondelli M; Guazzi GC
    Dev Neurosci; 1991; 13(4-5):280-7. PubMed ID: 1840098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of GM1-ganglioside beta-galactosidase by a specific inhibitor: a model for ganglioside storage disease.
    Singer HS; Tiemeyer M; Slesinger PA; Sinnott ML
    Ann Neurol; 1987 May; 21(5):497-503. PubMed ID: 3035998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution loading tests in the study of genetic heterogeneity in gangliosidosis fibroblasts.
    Akhunov VS; Mirenburg TV; Krasnopolskaya XD
    J Inherit Metab Dis; 1994; 17(1):104-11. PubMed ID: 8051915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.